Good evening. I'm Megan LeDuc, Manager of Investor Relations at Ginkgo Bioworks. I'm joined by Jason Kelly, our Co-Founder ...

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the ...

In this article, we are going to take a look at where Merck & Co. Inc. (NYSE ... Earlier in October, Jason Trennert, Strategas Research Partners chairman and CEO, joined CNBC to discuss the ...

Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress on cost reductions Ginkgo signs ...

Earlier in October, Jason Trennert, Strategas Research Partners ... beating its benchmark by 150 percentage points (see more details here). Merck & Co. Inc. (NYSE:MRK) is a global pharmaceutical ...

In a report released yesterday, Jason Zemansky from Bank of America Securities maintained a Hold rating on Arcus Biosciences (RCUS – ...

Taking a new tack There's no word yet on the drug targets that will be explored in the Cerevance partnership, but Merck head of neuroscience discovery, Jason Uslaner, said that the collaboration ...

Updated clinical data from VISTA101 presented at SITC 2024.Monotherapy arm fully enrolled and combination arm expected to be fully enrolled by ...

Teledyne Technologies Incorporated today announced that George Bobb, President and Chief Operating Officer, and Jason VanWees, Vice Chairman, will participate at the Baird 2024 Global Industrial ...

Q3 2024 Earnings Call Transcript October 31, 2024 8:30 AM ETCompany ParticipantsJennifer Halchak - VP, IRKevin Ali - ...